bullish
Unique biopharmaceutical company with high barrier of entry, high growth expected, take the deal
281 Views29 May 2015 15:08
3SBio is a leading biopharmaceutical company based in China offering products including EPIAO to cure anemia in Chronic Kidney Disease (CKD),...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 3-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- 3SBio: Valuation Trap with Tell-Tale Signs of Corporate Governance Issues02 Mar 2020
- Unique biopharmaceutical company with high barrier of entry, high growth expected, take the deal29 May 2015
- A Leading Chinese Biotech Company, Quality Cornerstones, Take the Deal29 May 2015
x